STAGE III NSCLC
Clinical trials for STAGE III NSCLC explained in plain language.
Never miss a new study
Get alerted when new STAGE III NSCLC trials appear
Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost survival in elderly lung cancer patients
Disease control Recruiting nowThis study tests whether giving immunotherapy (Cemiplimab) along with chemotherapy (Carboplatin and Paclitaxel) before radiation can help elderly or unfit patients with stage III non-small cell lung cancer live longer without their cancer getting worse. The trial will enroll 152 …
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo before surgery aims to control advanced lung cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy and immunotherapy (tislelizumab) given before surgery for people with stage III PD-L1 positive non-small cell lung cancer. The goal is to see if this approach helps more patients have successful surgery to remove all cancer. About 30…
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC